The gut microbiota as a therapeutic target for obesity: a scoping review.

Nutrition Research Reviews
Stephanie Santos-PauloRobert V Bryant

Abstract

There is mounting evidence that microbiome composition is intimately and dynamically connected with host energy balance and metabolism. The gut microbiome is emerging as a novel target for counteracting the chronically positive energy balance in obesity, a disease of pandemic scale which contributes to >70 % of premature deaths. This scoping review explores the potential for therapeutic modulation of gut microbiota as a means of prevention and/or treatment of obesity and obesity-associated metabolic disorders. The evidence base for interventional approaches which have been shown to affect the composition and function of the intestinal microbiome is summarised, including dietary strategies, oral probiotic treatment, faecal microbiota transplantation and bariatric surgery. Evidence in this field is still largely derived from preclinical rodent models, but interventional studies in obese populations have demonstrated metabolic improvements effected by microbiome-modulating treatments such as faecal microbiota transplantation, as well as drawing attention to the unappreciated role of microbiome modulation in well-established anti-obesity interventions, such as dietary change or bariatric surgery. The complex relationship between mi...Continue Reading

References

Oct 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Fredrik BäckhedJeffrey I Gordon
Feb 9, 2005·The American Journal of Clinical Nutrition·Loren CordainJanette Brand-Miller
Mar 26, 2005·Science·Fredrik BäckhedJeffrey I Gordon
Mar 26, 2005·Science·Justin L SonnenburgJeffrey I Gordon
Jul 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ruth E LeyJeffrey I Gordon
Oct 21, 2006·The Journal of Clinical Investigation·Hang ShiJeffrey S Flier
Dec 22, 2006·Nature·Ruth E LeyJeffrey I Gordon
Dec 22, 2006·Nature·Peter J TurnbaughJeffrey I Gordon
Apr 26, 2007·Diabetes·Patrice D CaniRémy Burcelin
Mar 11, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mathieu MembrezChieh Jason Chou
Dec 2, 2008·Nature·Peter J TurnbaughJeffrey I Gordon
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Husen ZhangRosa Krajmalnik-Brown
Apr 4, 2009·Nature Reviews. Immunology·June L Round, Sarkis K Mazmanian
Apr 9, 2009·Nature Biotechnology·Matthias H TschöpChristopher L Karp
Nov 11, 2009·Current Opinion in Gastroenterology·Ruth E Ley
Mar 17, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·R LuotoE Isolauri
May 29, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Claire Barbier de La SerreHelen E Raybould
Jun 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·Maria G Dominguez-BelloRob Knight
Aug 6, 2010·The ISME Journal·Alan W WalkerHarry J Flint
Jan 12, 2011·Annual Review of Immunology·Margaret F Gregor, Gökhan S Hotamisligil
Apr 22, 2011·Nature·Manimozhiyan ArumugamPeer Bork
Aug 30, 2011·Lancet·Boyd A SwinburnSteven L Gortmaker
Feb 22, 2012·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·A Bonakdar TehraniS Srinivasan
Jun 16, 2012·Nature·UNKNOWN Human Microbiome Project Consortium
Jun 16, 2012·Nature·Tanya YatsunenkoJeffrey I Gordon
Nov 1, 2012·The British Journal of Nutrition·Mohamed BellahceneJonathan R S Arch
Mar 29, 2013·Science Translational Medicine·Alice P LiouLee M Kaplan
Sep 7, 2013·Science·Vanessa K RidauraJeffrey I Gordon
Nov 10, 2013·Nature Medicine·Oluf PedersenAndrew Gewirtz
Jan 15, 2014·PloS One·Mariel M FinucaneKatherine S Pollard
Mar 29, 2014·Nature·Karen K RyanRandy J Seeley
Sep 10, 2014·Nature Reviews. Microbiology·Petra LouisHarry J Flint
Oct 10, 2014·International Journal of Obesity : Journal of the International Association for the Study of Obesity·N T MuellerA Rundle
Dec 10, 2014·Nature Reviews. Endocrinology·Laura M Cox, Martin J Blaser
Jan 16, 2015·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·K C G de Git, R A H Adan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Related Papers

Annals of the New York Academy of Sciences
Clare J LeeNisa Maruthur
Best Practice & Research. Clinical Gastroenterology
Petia Kovatcheva-Datchary, Tulika Arora
Journal of the American Association of Nurse Practitioners
Christy Blanco
© 2021 Meta ULC. All rights reserved